Point-spectroscopy Trial

MolecuLight Inc.11 enrolled

Overview

Evaluation and characterization of autofluorescence signals of tissue in and around wounds as identified by MolecuLight fluorescence image.

Evaluate and characterize autofluorescence signals of tissue components in and around wounds identified by MolecuLight FL images using a point spectrometer. The fluorescence spectroscopy data will yield quantitative spectral information, including the relative intensity and emission peak of the biological autofluorescence signatures.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Wound Wound of Skin

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients presenting with acute or chronic wounds * 18 years or older * Willing to consent Exclusion Criteria: * Treatment with an investigational drug within 1 month of enrolment * Any contra-indication to regular wound care * Inability or unwillingness to consent

Locations (1)

Judy Dan Centre for Hyperbaric Medicine & Advance Wound Care

North York, Ontario, Canada

Outcomes

Primary Outcomes

Spectra of autofluorescent signatures of tissue in and around the wounds

Spectral characterization (i.e. emission curve including intensity) of the autofluorescence signal from wound tissue and surrounding tissue will be catalogued from all 50 study participants.

Time frame: 2 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.